Purpose: Although cytologic examination of CSF is the primary method for th
e evaluation of response to therapy for leptomeningeal metastases (LMMs), t
he procedure's sensitivity decreases throughout the course of protracted th
erapy. We studied whether this response could be monitored more accurately
through the detection of numerical chromosomal aberrations by interphase cy
togenetics, using fluorescence in situ hybridization (FISH),
Patients and Methods: Seven patients treated for LMMs and with a known nume
rical aberration for chromosome; 1 in their pretreatment CSF were included
in this study, Up to 16 consecutive CSF samples were analyzed by means of t
he fluorescence in situ hybridization (FISH) technique for cells with aberr
ant chromosome 1 content, The results of routine cytology and FISH analyses
were compared and were correlated with each patient's neurologic status.
Results: Routine cytology detected malignancies in only 24 of the 76 sample
s, all of which were classified as chromosomally abnormal by FISH (except f
or two samples that could not be evaluated). Moreover, FISH demonstrated an
eusomic cells in 32 additional samples, which could therefore be classified
as malignant, The FISH results correlated better with patient neurologic s
tatus in that more malignant cells were detected in the CSF of neurological
ly deteriorating patients.
Conclusion: Using FISH in addition to performing routine cytologic examinat
ion of CSF leer to a more accurate evaluation of response to treatment in p
atients treated for LMMs. J Clin Oncol 18:2053-2058. (C) 2000 by American S
ociety of Clinical Oncology.